Mary Chaohong Hu

Mary Chaohong Hu

Company: Shanghai Miracogen

Job title: Chief Executive Officer


Navigating Strategic Collaborations to Make a Mark in the ADC World 1:05 pm

Numerous high-profile collaborations in Asia have propelled the scope of innovation in the region. Thus, partnering with external companies has become a strategic decision to increase your footing in the field. This interactive session will answer key collaborations questions to help you navigate the partnership landscape and foster strong relationships especially with mega pharma. Join…Read more

day: Pre-Conference Workshop Day

Exploring the Clinical Results of MRG003 & MRG004A to Develop EFGR Targeted ADCs 8:30 am

Comprehensive review of five ADCs currently in clinical studies Outline updated clinical results on nasopharyngeal carcinoma and HNSCC for MRG003, an EGFR targeted ADC Gain a clinical update for MRG004A, a TF targeted ADCRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.